Number of pages: 100 | Report Format: PDF | Published date: January 01, 2021
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
According to the deep-dive market assessment study by Growth Plus Reports, the global infertility treatment market was valued at US$ 1.58 billion in 2022 and is expected to register a revenue CAGR of 7.90% to reach US$ 3.14 billion by 2031.
Infertility Treatment Market Fundamentals
Infertility refers to the inability of a couple to conceive due to issues with the female or male reproductive system. As women age, their fertility progressively decreases. For men, an unhealthy lifestyle, smoking, and alcohol consumption have been linked to infertility. Treatment for infertility often involves hormone and ovulation-regulating medications, sometimes accompanied by minor surgical procedures.
The demand for infertility treatments is increasing due to lifestyle factors like delayed parenthood, stress, sedentary lifestyles, and obesity, causing a rise in infertility cases. Additionally, the availability of advanced healthcare infrastructure, especially in emerging nations, is expected to contribute to revenue growth. Furthermore, the market demand is likely boosted by improved infertility treatment options provided through telemedicine in rural areas.
Additionally, various strategies are being implemented by players in the infertility treatment market to increase the market revenue. Research and development investments are being made to develop advanced technologies and treatment options. Enhancements to assisted reproductive technologies (ART), including in-vitro fertilization (IVF), embryo transfer procedures, and genetic screening methods, are also being pursued. In addition, infertility treatment centers are expanding their treatment facilities by opening new clinics and expanding their reach to other locations.
Infertility Treatment Market Dynamics
Rising incidences of infertility is the prominent factor driving the infertility treatment market. Therefore, the infertility treatment market is expected to grow significantly in the coming years as more and more people seek medical assistance to overcome their fertility issues. Technological advancements in infertility treatments are expected to increase the revenue share of the infertility treatment market in the coming years. For instance, the most recent advances in reproductive health are centered on digitalizing healthcare data and workflows. Electronic witnessing systems that employ barcodes to ensure accurate monitoring of sperm, eggs, & embryos, robotic cryopreservation systems, and artificial intelligence-led (AI) technologies contribute to advancing reproductive health. These technological advancements are particularly beneficial for patients who have delayed parenthood, as they offer improved precision, efficiency, and success rates in infertility treatments.
Increased investments in research and development are expected to boost the revenue share of the infertility treatment market. For instance, Alife Health received a $22 million investment in March 2022. The AI-led brand has moved from its R&D phase into early traction and commercialization, aiming to create a full operating system for the next generation of IVF care delivery. Alife Health intends to launch two patient products in 2023 that will promote health equality in the IVF industry by assisting patients regardless of where they get treatment.
Infertility treatments have become more affordable for a greater population as disposable income has increased, particularly in emerging nations. Furthermore, medical tourism has become popular, with individuals and couples moving to nations that provide high-quality, low-cost infertility treatments. This pattern has increased the demand for infertility treatments in these locations.
However, factors such as the high cost of treatment, lack of insurance coverage, and limited availability of treatment in certain regions can restrain the infertility treatment market growth.
Infertility Treatment Market Ecosystem
The global infertility treatment market is analyzed from the following perspectives: product type, procedure type, gender, end user, and region.
Infertility Treatment Market by Product Type
Based on product type, the global infertility treatment market is segmented into equipment, media & consumables, and accessories.
The equipment segment accounted for the majority of revenue share in the infertility treatment market. The segment is sub-segmented into microscopes, imaging systems, sperm analyzers systems, sperm separation devices, ovum aspiration pumps, micromanipulators systems, incubators, and others (gas analyzers, laser systems, cryptosystems, etc. However, the media & consumables segment is expected to register 8.6% of revenue CAGR in the forecast years. This can be attributed to the increasing demand for media and consumables for in vitro fertilization (IVF) procedures. As technological advancements in fertility treatment continue to progress, there is a growing need for advanced media formulations and consumables that can optimize embryo development, increase success rates, and ensure the safety of both patients and embryos.
Infertility Treatment Market by Procedure
Based on procedures, the global infertility treatment market is segmented into assisted reproductive technology, artificial insemination, and fertility surgery.
The assisted reproductive technology segment accounted for the majority of the revenue share in the global infertility treatment market. The segment is sub-segmented into in vitro fertilization, intracytoplasmic sperm injection, gamete intrafallopian transfer, and others. The dominance of assisted reproductive technology is majorly due to the increased adoption of assisted reproductive technology with greater success rates. The Centers for Disease Control and Prevention states that every year, around 2.0% of all children born in the United States are conceived via assisted reproductive technology. Moreover, technological advancements in in-vitro fertilization are also expected to increase the revenue share of the assisted reproductive technology segment in the forecast years. For instance, the use of preimplantation genetic testing has allowed for more successful pregnancies and reduced instances of genetic disorders in newborns.
Infertility Treatment Market by Gender
Based on gender, the global infertility treatment market is segmented into males and females. The female segment dominated the global infertility treatment market with the largest revenue share in 2022. This can be attributed to the higher prevalence of female infertility and the availability of a wider range of treatment options for women, including assisted reproductive technologies such as in vitro fertilization (IVF) and intrauterine insemination (IUI). According to the Centers for Disease Control and Prevention 2022 estimates, approximately 19% of married women aged 15 to 49 years who have never given birth experience infertility after one year of trying to conceive. Additionally, nearly 26% of women in this group may face challenges in conceiving or carrying a pregnancy to term, known as impaired fecundity.
Infertility Treatment Market by End User
Based on end user, the global infertility treatment market is segmented into hospitals & clinics, fertility clinics, others (cryobanks, research institutes, etc.)
The fertility centers segment is anticipated to be the fastest-growing segment during the forecast period. This is attributed to the increasing number of fertility centers across the globe. Moreover, the rising prevalence of infertility, advancements in reproductive technologies, and growing awareness regarding infertility treatments are expected to drive the growth of the fertility centers segment in the forecast years.
Infertility Treatment Market by Region
Based on the region, the global infertility treatment market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.
The North America region dominated the infertility treatment market with the majority of the revenue share. This is majorly attributed to the increasing incidence of infertility in North America. According to the National Institute of Child Health and Human Development, in 2018 the United States, around 9% of males and 11% of women of reproductive age suffer from fertility issues. Moreover, with advancements in technology and increasing awareness about infertility, the infertility treatment market is expected to witness significant growth in the near future.
The rising incidence of infertility characterizes the European infertility treatment market. Infertility has increased dramatically in the country during the previous 60 years. According to the Office for National Statistics (ONS) report issued in 2019, the birth rate in Wales and England reached a record low in 2018. The significant reduction is mostly due to falling fertility rates and an older population. In terms of obesity prevalence, Germany is among the top countries.
The infertility treatment market in the Asia Pacific is expected to experience significant growth in the coming years due to increasing awareness about infertility and the availability of advanced treatment options. The region is also witnessing a rise in infertility cases, further driving the demand for infertility treatments. According to the WHO, in 2022, the prevalence of infertility in India ranges between 3.9% and 16.8%. Rising technological advancements in treating infertility are also boosting the market revenue share in projected years. Moreover, increasing healthcare standards and rising disposable income are also supporting the revenue share of the Infertility treatment market in Asia Pacific.
Infertility Treatment Market Competitive Landscape
The competitive landscape of the global infertility treatment market is highly competitive, with the presence of several key players such as Cooper Companies, Inc., Cook Group, and Vitro Life. These companies are constantly engaged in research and development activities to introduce innovative products in the market and gain a competitive edge. Additionally, strategic collaborations, mergers, and acquisitions are key strategies these players adopt to expand their market presence.
Some of the prominent companies having the largest revenue share in the global infertility treatment market are,
Infertility refers to the inability of a couple to conceive due to issues with the female or male reproductive system.
The global infertility treatment market is expected to reach US$ 3.14 billion by 2031.
The global infertility treatment market has experienced significant growth in recent years, driven by technological advancements and increasing demand, mostly for people with delayed motherhood.
The global infertility treatment market is expected to register a revenue CAGR of 7.90% in the forecast year.
North America accounted for the majority of the revenue share in the global infertility treatment market.
*Insights on financial performance are subject to the availability of information in the public domain